Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(20)
DRUG(2)
Computed Tomography
5 trials
early_phase_1phase_2
jonsson-comprehensive-cancer-center
Positron Emission Tomography
4 trials
early_phase_1phase_2
jonsson-comprehensive-cancer-center
Gallium Ga 68 Gozetotide
2 trials
phase_2
jonsson-comprehensive-cancer-center
Single Photon Emission Computed Tomography
2 trials
early_phase_1phase_2
jonsson-comprehensive-cancer-center
Gallium Ga 68 FAPi-46
2 trials
early_phase_1
jonsson-comprehensive-cancer-center
18F-FDG
2 trials
early_phase_1
jonsson-comprehensive-cancer-center
99mTc-based PSMA Imaging and Surgery Agent
1 trial
early_phase_1
jonsson-comprehensive-cancer-center
Gallium Ga 68-labeled PSMA-11
1 trial
early_phase_1
jonsson-comprehensive-cancer-center

+3 more interventions

11 unique interventions2 categories

Analytics

Trial Phases

Phase 22

Trial Status

Recruiting2
Terminated1
Other2

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT06288113Phase 2Recruiting
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
PrincipalinvestigatorStart date: 2024-08-01
NCT04928820Phase 2Terminated
68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
PrincipalinvestigatorStart date: 2021-06-16
NCT04857502Early Phase 1Recruiting
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
Prostate CarcinomaRecurrent Prostate Carcinoma
PrincipalinvestigatorStart date: 2021-04-27
NCT04457258Early Phase 1Active Not Recruiting
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Metastatic SarcomaRecurrent SarcomaSarcoma
PrincipalinvestigatorStart date: 2020-09-08
NCT04147494Early Phase 1Active Not Recruiting
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Breast CarcinomaColon CarcinomaEsophageal Carcinoma+8 more
PrincipalinvestigatorStart date: 2019-11-05

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Sarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Claudia Valverde

Hospital Universitari Vall d'Hebrón

Related
3 trials

Shared therapeutic areas:

Sarcoma
Similarity Score1%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Sarcoma
Similarity Score1%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Sarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Sarcoma
Similarity Score1%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Ovarian Carcinoma
Similarity Score1%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Sarcoma
Similarity Score1%

Jean-Olivier ARNAUD, Director

Assistance Publique Hôpitaux de Marseille

Related
17 trials

Shared therapeutic areas:

Sarcoma
Similarity Score1%

Javier Martín Broto

Hospital Universitario Fundación Jiménez Díaz

Related
5 trials

Shared therapeutic areas:

Sarcoma
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06288113Phase 2PrincipalInvestigator

Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial

Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Recruiting
NCT04928820Phase 2PrincipalInvestigator

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Terminated
NCT04857502Early Phase 1PrincipalInvestigator

99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

Prostate CarcinomaRecurrent Prostate Carcinoma
Recruiting
NCT04457258Early Phase 1PrincipalInvestigator

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

Metastatic SarcomaRecurrent SarcomaSarcoma
Active Not Recruiting
NCT04147494Early Phase 1PrincipalInvestigator

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Breast CarcinomaColon CarcinomaEsophageal Carcinoma+8 more
Active Not Recruiting

All 5 trials loaded